Timothy J. Keiffer

Founder at enGene, Inc.

Health Technology

Consumer Services

Profile

Timothy J.
Keiffer is the founder of enGene, Inc., a company founded in 1999.
He holds the title of Vice President-Research at enGene, Inc. since 2011.
Currently, Dr. Keiffer is a Professor at the University of British Columbia.
He obtained a doctorate degree from the University of British Columbia.

Timothy J. Keiffer active positions

Companies	Position	Start
enGene, Inc. enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.	Founder	2010-02-14
University of British Columbia	Corporate Officer/Principal	2011-05-24

All active positions of Timothy J. Keiffer

Training of Timothy J. Keiffer

University of British Columbia

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Timothy J. Keiffer's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
enGene, Inc. enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.	Health Technology